CN Stock MarketDetailed Quotes

603590 Beijing Konruns Pharmaceutical

Watchlist
  • 25.25
  • +0.20+0.80%
Trading Jul 12 14:14 CST
4.04BMarket Cap24.28P/E (TTM)

Beijing Konruns Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beijing Konruns Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 26, 2024

Revenue(YoY)

199.24M

+20.67%
EPS(YoY)

0.27

+68.75%
Analyst Rating

Strong Buy

Jul 12, 2024

Beijing Konruns Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.283B--
--2024/FY-- / 1.077B--
--2023/FY920.012M / 1.049B--
--2022/FY866.726M / 877.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.283B--
--2024/FY-- / 1.077B--
--2023/FY920.012M / 1.049B--
--2022/FY866.726M / 877.000M--
--------

Unlock Free Earnings Estimates

Beijing Konruns Pharmaceutical Earnings Reports

  • Kangchen Pharmaceutical's Announcement on Corrections to the 2023 Annual Report and Annual Report Summary

    May 5 12:00 ET

  • Kangchen Pharmaceutical 2023 Annual Report (Revised Edition)

    May 5 12:00 ET

  • Kangchen Pharmaceutical 2023 Annual Report Summary (Revised Edition)

    May 5 12:00 ET

  • Kangchen Pharmaceutical 2023 Annual Report Summary

    Apr 25 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 12, 2024

    Strong Buy

    • Strong Buy

      90.00%

    • Buy

      10.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg